Dr. Stoxx Blog

Can CONN Carry-On Higher?

The following article is an analysis of a stock that recently appeared in The HOT STOXX LETTER from DrStoxxtrading.  The author and the letter subscribers may have a position in the stock at the time of publication.

About the HOT STOXX LETTER (averages +158.3% ROI/year): The HOT STOXX LETTER is a limited premium advisory that selects the 3 best momentum stocks each week.  All stocks are selected by Dr. Thomas Carr, founder and CEO of the Dr. Stoxx brand, and author of the bestselling book, Trend Trading for a Living (McGraw-Hill).  Subscriptions include $1,199 in free trading resources.  200 max members only.  Available only […]

Can the Rally in $CVNA Continue?

The following article is sponsored by DrStoxx.com

“Helping active traders make money in the markets since 2002”

The Trend Trade Letter: +34% annual ROI since 2002

The Cheap Stocks Letter: +59% annual ROI since 2007

The ETF Trend Letter: +65% annual ROI since 2010

The Momentum Letter: +82% annual ROI since 2012

Carvana Co. (Nasdaq: CVNA) is one of the few bright spots in this year’s rather dull crop of IPOs.  Shares of the stock initially sold off following its first day of trading as investors were wary that its disruptive way of selling used cars (mail order?  vending machine?) was more about gimmicks than […]

Spicy $SAUC: worth a nibble here

​Disclaimer: we are LONG shares of $SAUC in The Dr. Stoxx Options Letter (sold on Marketfy.com) and it is also a stock selected for previous issues of THE MOMENTUM LETTER as sold on DrStoxx.com.

Diversified Restaurant Holdings, Inc.

Nasdaq: SAUC

Industry: Franchise Restaurants

Market Cap: $86M (Smallcap)

P/E: 21.5

P/Sales: 0.5

P/Free Cash Flow: 9.0

Diversified Restaurant Holdings ($SAUC) operates the Buffalo Wild Wings Grill and Bar franchise throughout the United States.  As of March this year, the company had 64 franchised restaurants in 5 states producing $162M in sales (nearly double the market cap) and $4M in net income.  Income grew 801% this year and are projected […]

$REGI: the best clean energy play right now

The following stock was selected by our proprietary MOMENTUM-PEAR strategy. This method is featured in the new HOT STOXX LETTER, set to launch very soon. Limited enrollment: 200 max. subscribers. For more information, see below or email us at: support@drstoxx.com

——————————————————————————————————-

Renewable Energy Group (Nasdaq: REGI) is headquartered in Iowa and has been producing clean burning, low CO2 emission fuel since 1996. They turn feed and agri waste into carbon based diesel at a cost of only half of the carbon emissions created by petroleum companies. Nice!

And the company is hugely profitable, trading at super low valuation metrics, and it grew […]

$SNAP: the new $FB or the next $TWTR fail?

SPECIAL OFFER: To celebrate our 15th year publishing award winning stock pick letters, please use ​HALFOFF in the discount code box at checkout at www.drstoxx.com to take 50% off your first monthly or quarterly payment.

So is Snapchat (Nasdaq: SNAP) the next Facebook (+360% since IPO) or the next Twitter (-80% since its IPO)? I’m not sure, and only time will tell. But for the very near term, shares of SNAP look to be putting in a constructive bottom after trading below $18 (-25% below its opening day price) briefly following a very disappointing earnings report. The massive volume flush […]

$SAUC: Time to Nibble on This Food Stock

We own shares of $SAUC in our private account.

$SAUC is one of the Top 3 Longs in The Momentum Letter as sold on DrStoxx.com.  The Momentum Letter is published weekly and is our most profitable stock letter.

Diversified Restaurant Holdings, Inc.                Nasdaq: $SAUC

Market Cap: $76M

P/E: 21.8                 PEG: 1.2                 P/Sales: 0.46

EPS Growth this Year: 810%

Diversified Restaurant Holdings, founded in 1999, operates 64 Buffalo Wild Wings Grill throughout the U.S.  The stock has been on a tear ever since reporting better than […]

Spartan Motors Racing Higher ($SPAR)

This stock pick was selected by The Momentum Letter Trading System.  For more information on The Momentum Letter, please click here.

Spartan Motors (Nasdaq: SPAR)

Market Cap: $297M

Industry: Specialty Vehicles and Parts

Shares of Spartan Motors are up 63% over the past 12 months, including a 42% rally since early March.  Shares trade at only 0.5x sales and under 2x book value.  EPS grew 150% this year and 60% per year over the past 5 years.  With little debt, a 1.1% dividend, and a buy or better from analysts, this is a relative safe momentum play to buy now and hold for […]

Buy Tronox (TROX) for the Upside Breakout

Market Talks with Dr. Stoxx  

DrStoxx.com

NYSE: $TROX

Tronox Limited

Market Cap: $2.0B

NOTE: WE ARE LONG TROX IN THE DR. STOXX OPTIONS LETTER (click here)

Tronox produces and sells titanium based chemicals and pigments that have a variety of industrial applications.  Shares trade at 22x forward eps, under 1x sales, under 2x price to book value; on 81% eps growth this year and 107% projected growth.  This momentum play is up 147% over the past 12 months, including a 56% ramp year to date.  Shares pay 1.2% and that is expected to increase this year on growing revenues.  The company’s recent purchase of […]

Big Cap Momo Play: CENTENE Corp. ($CNC)

Market Talks with Dr. Stoxx  

DrStoxx.com  IXTHYSLetter.com

NYSE: CNC

Centene Corporation

Index: S&P 500

Market Cap: $13.1B

Centene works with governments to provide quality health care to those with little or no insurance.  It is a component of the S&P500, and has recently shown up on our “Conservative Momentum” stock screen.  It is currently one of the selections among our “Top 3 Conservative Momentum Stocks” listed in The Momentum Letter (www.DrStoxx.com).  The stock is undervalued, trading at under 19x earnings and 14x forward earnings per share, on only 0.3x sales revenues.  The company boasts a 5 year sales growth record of 51% per year and 720% […]

Buy Aceto Corporation Ahead of Earnings – ACET

$ACET is a BUY.

This producer of chemicals used in generic drugs is a recent addition to our IXTHYS Letter Portfolio. The company produces $545M in revenues and shares trade at a low 22x earnings, and 9x forward estimates. Net income has increased an average of 27% per year over the past 5 years. A 0.8x sales metric shows upside potential.

Zacks Research gives ACET a top rank of 1 (strong buy) for its recent upward revisions in earnings estimates.

Shares pay 1.6% dividend, and 10% of the float is short.  We may see a squeeze in play when the company reports […]